0

    540726

    TTFL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Trident Texofab Limited Share Price Today

    Investment Returns

    Over 1 Month -18.33% Over 3 Months -44.21% Over 6 Months -87.17% Over 1 Year -85.01%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Trident Texofab Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 46.60
    • P/E Ratio (TTM) 67.77
    • Beta 0.42
    • Book Value / share 37.06
    • Return on equity 2.61%
    • EPS (TTM) 0.88
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -2.01
    info icon alternate text

    Trident Texofab Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 33.57
    Operating Expense 35.41
    Net Profit -2.01
    Net Profit Margin (%) -5.98
    Earnings Per Share (EPS) -1.30
    EBITDA -1.58
    Effective Tax Rate (%) 13.73
    Particulars DEC 2025 (Values in Cr)
    Revenue 25.74
    Operating Expense 25.38
    Net Profit 0.57
    Net Profit Margin (%) 2.21
    Earnings Per Share (EPS) 0.39
    EBITDA 2.02
    Effective Tax Rate (%) 22.97
    Particulars SEP 2025 (Values in Cr)
    Revenue 30.63
    Operating Expense 29.52
    Net Profit 1.13
    Net Profit Margin (%) 3.68
    Earnings Per Share (EPS) 0.77
    EBITDA 2.88
    Effective Tax Rate (%) 25.16
    Particulars JUN 2025 (Values in Cr)
    Revenue 28.08
    Operating Expense 27.15
    Net Profit 1.02
    Net Profit Margin (%) 3.63
    Earnings Per Share (EPS) 0.72
    EBITDA 2.51
    Effective Tax Rate (%) 25.54
    Particulars MAR 2025 (Values in Cr)
    Revenue 38.21
    Operating Expense 38.25
    Net Profit 0.51
    Net Profit Margin (%) 1.33
    Earnings Per Share (EPS) 0.50
    EBITDA 1.78
    Effective Tax Rate (%) -34.21
    Particulars MAR 2026 (Values in Cr)
    Revenue 118.02
    Operating Expense 117.46
    Net Profit 0.70
    Net Profit Margin (%) 0.59
    Earnings Per Share (EPS) 0.54
    EBITDA 5.82
    Effective Tax Rate (%) 45.31
    Particulars MAR 2025 (Values in Cr)
    Revenue 122.06
    Operating Expense 122.78
    Net Profit 2.51
    Net Profit Margin (%) 2.05
    Earnings Per Share (EPS) 2.38
    EBITDA 8.78
    Effective Tax Rate (%) 2.71
    Particulars MAR 2024 (Values in Cr)
    Revenue 99.48
    Operating Expense 99.02
    Net Profit 1.08
    Net Profit Margin (%) 1.08
    Earnings Per Share (EPS) 1.07
    EBITDA 6.85
    Effective Tax Rate (%) 7.69
    Particulars MAR 2023 (Values in Cr)
    Revenue 96.36
    Operating Expense 95.39
    Net Profit 2.22
    Net Profit Margin (%) 2.30
    Earnings Per Share (EPS) 2.20
    EBITDA 8.08
    Effective Tax Rate (%) 18.68
    Particulars MAR 2022 (Values in Cr)
    Revenue 84.29
    Operating Expense 83.80
    Net Profit 0.98
    Net Profit Margin (%) 1.16
    Earnings Per Share (EPS) 0.98
    EBITDA 5.56
    Effective Tax Rate (%) 22.83
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 31.81
    ROE % 2.61
    ROCE % 9.82
    Total Debt to Total Equity 1.10
    EBITDA Margin 6.84
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 16.14
    ROE % 5.47
    ROCE % 11.75
    Total Debt to Total Equity 2.48
    EBITDA Margin 8.33
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 15.07
    ROE % 15.78
    ROCE % 15.10
    Total Debt to Total Equity 2.72
    EBITDA Margin 10.36
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 12.87
    ROE % 7.86
    ROCE % 7.87
    Total Debt to Total Equity 2.92
    EBITDA Margin 6.61
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 11.89
    ROE % 2.99
    ROCE % 8.67
    Total Debt to Total Equity 2.38
    EBITDA Margin 9.57
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.15
    Total Assets 100.57
    Total Liabilities 100.57
    Total Equity 47.23
    Share Outstanding 1
    Price to Book Ratio 5.50
    Return on Assets (%) 2.49
    Return on Capital (%) 3.4
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.15
    Total Assets 81.89
    Total Liabilities 81.89
    Total Equity 16.25
    Share Outstanding 1
    Price to Book Ratio 3.02
    Return on Assets (%) 1.31
    Return on Capital (%) 2.03
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.06
    Total Assets 77.30
    Total Liabilities 77.30
    Total Equity 15.17
    Share Outstanding 1
    Price to Book Ratio 3.82
    Return on Assets (%) 2.86
    Return on Capital (%) 4.45
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 70.98
    Total Liabilities 70.98
    Total Equity 12.95
    Share Outstanding 1
    Price to Book Ratio 4.81
    Return on Assets (%) 1.38
    Return on Capital (%) 2.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 67.77
    Total Liabilities 67.77
    Total Equity 11.97
    Share Outstanding 1
    Price to Book Ratio 2.17
    Return on Assets (%) 0.52
    Return on Capital (%) 0.82
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.57
    Cash from Operations -13.41
    Cash from Investing 4.49
    Cash from Financing 36.64
    Net change in Cash 27.42
    Free Cash Flow -13.41
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.16
    Cash from Operations 2.82
    Cash from Investing -0.57
    Cash from Financing -2.04
    Net change in Cash 0.09
    Free Cash Flow 2.88
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.72
    Cash from Operations 5.98
    Cash from Investing 0.37
    Cash from Financing -6.20
    Net change in Cash 0.02
    Free Cash Flow 6.19
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.27
    Cash from Operations 1.39
    Cash from Investing -4.38
    Cash from Financing 2.99
    Net change in Cash 0.00
    Free Cash Flow 5.55
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.90
    Cash from Operations 2.19
    Cash from Investing -10.19
    Cash from Financing 8.18
    Net change in Cash -0.04
    Free Cash Flow 12.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ARVIND LTD. 513.05 31.55 3.32 13449.13 275.00 600.00
    BLUE BLENDS (INDIA) LTD. 0.97 0.00 0.38 2.10 0.00 0.00
    BOMBAY DYEING & MFG. CO L 120.45 401.50 1.08 2487.71 92.10 196.50
    CENTURY ENKA LTD. 564.95 12.07 0.82 1234.42 371.30 622.00
    DELTA MANUFACTURING LIMITED 59.70 0.00 28.15 64.78 41.03 95.01
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ARVIND LTD. 513.05 47.77 4.37 13449.13 275.00 600.00
    BLUE BLENDS (INDIA) LTD. 0.97 0.00 0.40 2.10 0.00 0.00
    BOMBAY DYEING & MFG. CO L 120.45 401.50 1.10 2487.71 92.10 196.50
    CENTURY ENKA LTD. 564.95 11.97 0.82 1234.42 371.30 622.00

    Trident Texofab Limited shareholding pattern

    Holding
    67.84%
    32.15%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Trident Texofab Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    31.07 -2.44 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 32.20
    • 26 Days 34.80
    • 10 Days 32.60
    • 50 Days 40.90
    • 12 Days 32.80
    • 100 Days 67.80
    • 20 Days 33.90
    • 200 Days 113.90
    31.81 PIVOT
    First Support 31.22 First Resistance 32.44 Second Support 30.59 Second Resistance 33.03 Third Support 30.00 Third Resistance 33.66
    RSI 36.23 ADX 63.84 MACD -1.96 Williams % R -62.85 Commodity Channel Index (CCI) -66.16
    Date 2026-07-23 Week 9328.00 Same Day 1237.00 Month 10623.00
    1 Year 0.42 3 Year 0.28
    Over 1 Month
    -18.33% down
    Over 1 Year
    -85.01% down
    Over 3 Months
    -44.21% down
    Over 3 Years
    -20.40% down
    Over 6 Months
    -87.17% down
    Over 5 Years
    -1.29% down

    Trident Texofab Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    18 Jul 2019 1.0 Final 20 Jul 2019 Equity shares
    02 Jul 2018 1.0 Final 04 Jul 2018 Equity shares
    Ex-Date Ex-Bonus Ratio
    12 Aug 2020 11 Aug 2020 14:10

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Trident Texofab Ltd?

    Answer Field

    Trident Texofab Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 31.07 as on Jul 24 2026 03:29 PM.

    What is the Market Cap of Trident Texofab Ltd Share?

    Answer Field

    The market cap of Trident Texofab Ltd for NSE ₹ 0.00 & for BSE ₹ 46.60 as on Jul 24 2026 03:29 PM.

    What is the 52 Week High and Low of Trident Texofab Ltd?

    Answer Field

    The 52 Week High and Low of Trident Texofab Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 379.00 and ₹ 30.00.

    What is 1 year return for Trident Texofab Ltd?

    Answer Field

    The 1 year returns on the stock has been -85.01%.

    What is the P/E Ratio of Trident Texofab Ltd Share?

    Answer Field

    As on Jul 24 2026 03:29 PM the price-to-earnings (PE) ratio for Trident Texofab Ltd share is 67.77.

    What is the PB ratio of Trident Texofab Ltd Share?

    Answer Field

    As on Jul 24 2026 03:29 PM, the price-to-book (PB) ratio for Trident Texofab Ltd share is 37.06.

    How to Buy Trident Texofab Ltd Share?

    Answer Field

    You can trade in Trident Texofab Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Trident Texofab Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Trident Texofab Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Trident Texofab Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |